The effects of the dietary supplement Cardioflex on reducing cardiovascular disease risk factors in adults.
Heart disease and stroke are the leading causes of death and prescription drug use in Canada. In 2011, it was estimated that 1.6 million Canadians are living with heart disease or the effects of a stroke. One person every 7 minutes dies from heart disease or stroke in Canada. The purpose of this clinical trial is to take adults who are at risk for developing cardiovascular disease but are otherwise healthy and to determine whether daily supplementation with Cardioflex for 90 days will reduce their risk factor markers such as blood lipid (e.g. cholesterol and triglyceride).